Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/4E405BC673ABD780749EC079E42B5B1EDA8185FB601C49FE70365BE48DEC094EAF82AE8ED4602086BF41E5659968F5CChttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/4E405BC673ABD780749EC079E42B5B1EDA8185FB601C49FE70365BE48DEC094EAF82AE8ED4602086BF41E5659968F5CChttp://www.w3.org/2000/01/rdf-schema#comment"EphA2 mAb treatment could partially inhibit LPSinduced inactivation of EphBEphrin B3 signalling while Ephrin B3 overexpression could abrogate LPSinduced activation of EphA2Ephrin A1 signalling. EphB1/Ephrin B3 signalling may antagonise the EphA2/Ephrin A1dependent pathway following LPS treatment."xsd:string
http://purl.uniprot.org/uniprot/#_7C7B8DC0D819C49B7D1B5DEC9913918947F4155CF2B31E8D183228049902540E96863D75EB5F1846E79FC1E1BAE0D27Fhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/4E405BC673ABD780749EC079E42B5B1EDA8185FB601C49FE70365BE48DEC094EAF82AE8ED4602086BF41E5659968F5CC
http://purl.uniprot.org/uniprot/D3YTT5http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/4E405BC673ABD780749EC079E42B5B1EDA8185FB601C49FE70365BE48DEC094EAF82AE8ED4602086BF41E5659968F5CC
http://purl.uniprot.org/uniprot/#_D3YTT5-mappedCitation-29901151http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/4E405BC673ABD780749EC079E42B5B1EDA8185FB601C49FE70365BE48DEC094EAF82AE8ED4602086BF41E5659968F5CC